Gilead Sciences
(NASDAQ) GILD
Gilead Sciences Financials at a Glance
Market Cap
$155.26B
Revenue (TTM)
$29.73B
Net Income (TTM)
$9.22B
EPS (TTM)
$7.35
P/E Ratio
17.01
Dividend
$3.22
Beta (Volatility)
0.42 (Low)
Dividend
$3.22
Beta (Volatility)
0.42 (Low)
Price
$125.20
Volume
8,462,589
Open
$126.63
Price
$125.20
Volume
8,462,589
Open
$126.63
Previous Close
$125.05
Daily Range
$124.44 - $126.63
52-Week Range
$104.46 - $157.29
Estimated Earnings Date
Aug 6, 2026
Dividend
$3.22
Beta (Volatility)
0.42 (Low)
Price
$125.20
Volume
8,462,589
Open
$126.63
Previous Close
$125.05
Daily Range
$124.44 - $126.63
52-Week Range
$104.46 - $157.29
Estimated Earnings Date
Aug 6, 2026
GILD News
Best Biotech ETFs to Buy in 2026
GILD: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Gilead Sciences
Industry
Biotechnology
Sector
Health CareEmployees
17,000
CEO
Daniel P. O'Day, MBA
Website
www.gilead.comHeadquarters
Foster City, CA 94404, US
GILD Financials
Key Financial Metrics (TTM)
Gross Margin
79.35%
Operating Margin
38.26%
Net Income Margin
30.99%
Return on Equity
42.16%
Return on Capital
24.74%
Return on Assets
16.38%
Earnings Yield
5.88%
Dividend Yield
2.57%
Payout Ratio
43.76%
Stock Overview
Market Cap
$155.26B
Shares Outstanding
1.24B
Volume
8.46M
Avg. Volume
6.79M
Financials (TTM)
Gross Profit
$23.60B
Operating Income
$11.38B
EBITDA
$14.02B
Operating Cash Flow
$10.81B
Capital Expenditure
-$576.00M
Free Cash Flow
$10.23B
Cash & ST Invst.
$9.82B
Total Debt
$22.17B
Gilead Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$6.96B
+4.4%
Gross Profit
$5.52B
+7.6%
Gross Margin
79.24%
N/A
Market Cap
$155.26B
N/A
Market Cap/Employee
$8.82M
N/A
Employees
17,600
N/A
Net Income
$2.02B
+53.7%
EBITDA
$3.04B
+16.7%
Quarterly Fundamentals
Total Cash
$9.82B
+23.9%
Total Debt
$22.17B
-11.1%
Accounts Receivable
$4.74B
+8.0%
Inventory
$1.91B
+8.8%
Long Term Debt
$20.86B
-5.8%
Short Term Debt
$1.31B
-53.2%
Return on Assets
16.38%
N/A
Return on Invested Capital
24.30%
N/A
Free Cash Flow
$2.43B
+46.8%
Operating Cash Flow
$2.54B
+44.8%